Increased photosensitivity in HL60 cells expressing wild-type p53

Area of Science:

• Oncology
• Cell Biology
• Photobiology

Background:

• p53 tumor suppressor gene loss correlates with reduced sensitivity to conventional cancer therapies.
• The role of p53 status in response to photodynamic therapy-induced oxidative stress remains largely uninvestigated.

Purpose of the Study:

• To investigate the impact of p53 functional status (wild-type, mutated, or deleted) on photosensitivity in human promyelocytic leukemia HL60 cells.
• To compare the efficacy of different photosensitizers (purpurin- and porphyrin-based) in relation to p53 status.

Main Methods:

• Human promyelocytic leukemia HL60 cell lines with varying p53 expression (wild-type, mutated, deleted) were utilized.
• Cells were treated with tin ethyl etiopurpurin (SnET2) or Photofrin (PH) photosensitizers and exposed to light or UVC irradiation.
• Cell survival was assessed, and photosensitizer accumulation and cellular uptake were measured.

Main Results:

• HL60 cells expressing wild-type p53 exhibited significantly higher sensitivity to photosensitization (SnET2 and PH) and UVC irradiation compared to cells with mutated or deleted p53.
• While total SnET2 accumulation was similar across cell lines, Photofrin uptake was higher in wild-type p53 cells, though this could be normalized.
• Photosensitizer-induced oxidative stress triggered a rapid apoptotic response in all tested cell lines, irrespective of p53 status.

Conclusions:

• Wild-type p53 status confers increased photosensitivity in HL60 leukemia cells.
• Photodynamic therapy-induced oxidative stress can effectively induce apoptosis via a p53-independent pathway in these cells.